US 'not targeting' India, says FDA chief

In this handout photograph from the Federation of Indian Chambers of Commerce and Industry on February 11, 2014, US Food and Drug Administration commissioner, Margaret Hamburg (R) and Secretary General of FICCI, A Didar Singh meet in New DelhiUS regulators are not targeting India, despite a series of import restrictions on drugs from the major US trading partner, the Food and Drug Administration chief said Friday. FDA Commissioner Margaret Hamburg briefed reporters after her first official trip to India, where she met with government and industry leaders earlier this month. India is the second largest US supplier of prescription and over-the-counter drugs, and its big pharma companies Ranbaxy and Wockhardt have been hit with multiple US import suspensions due to safety concerns. Hamburg said the FDA has ramped up inspections at Indian drug plants as part of a global effort to improve safety.

Share this article